SCHEMBL24377055

SCHEMBL24377055

c1ccc(-c2ccc3cc(-c4nc(-c5ccc6ccccc6c5)nc(-c5ccc6cccc(-c7ccccc7)c6c5)n4)ccc3c2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TNF P01375 1/20 0.45
HSD17B1 P14061 2/20 0.45
HSD17B2 P37059 2/20 0.45
CA12 O43570 2/20 0.44
CA1 P00915 2/20 0.44
CA2 P00918 2/20 0.44
CA9 Q16790 2/20 0.44
ESR1 P03372 3/20 0.43
ESR2 Q92731 3/20 0.43
KDM4E B2RXH2 2/20 0.43
ALDH1A1 P00352 2/20 0.43
TP53 P04637 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
HSD17B10 Q99714 2/20 0.43
MEN1 O00255 1/20 0.43
CYP1A2 P05177 1/20 0.43
KMT2A Q03164 1/20 0.43
CYP17A1 P05093 1/20 0.42
CYP19A1 P11511 1/20 0.42
CYP11B1 P15538 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17655973 0.98 ALDH1A1 (0.45) TNFHSD17B1HSD17B2CA12CA1
SCHEMBL27455921 0.98 ALDH1A1 (0.45) TNFHSD17B1HSD17B2CA12CA1
SCHEMBL24377123 0.98 TNF (0.46) TNFHSD17B1HSD17B2CA12CA1
SCHEMBL24377092 0.97 HSD17B1 (0.45) TNFHSD17B1HSD17B2CA12CA1
SCHEMBL23633494 0.97 TNF (0.47) TNFHSD17B1HSD17B2CA12CA1
SCHEMBL27455712 0.95 ALDH1A1 (0.45) TNFHSD17B1HSD17B2CA12CA1
SCHEMBL17655849 0.95 ALDH1A1 (0.45) TNFHSD17B1HSD17B2CA12CA1
SCHEMBL23633719 0.95 ALDH1A1 (0.47) TNFHSD17B1HSD17B2CA12CA1
SCHEMBL25680776 0.94 ALDH1A1 (0.44) TNFHSD17B1HSD17B2CA12CA1
SCHEMBL25816528 0.94 CA12 (0.49) TNFHSD17B1HSD17B2CA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220131082-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2022-04-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220131082-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF NFE2L2, OR51E2, ETV6 TNF 2928/4885HSD17B1 3492/4885HSD17B2 2954/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.